Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

In this regard, we highlight three generic drugmakers — Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS — which are well-positioned to navigate these headwinds due to their global ...

The launch of generic versions of Restasis and Revlimid, and the full FDA approval of generic Symbicort (Breyna) have boosted the company’s top line and should accelerate growth.

3 Generic Drug Stocks to Keep an Eye On Sandoz: This Swiss-based generic drugmaker, which spun off from Novartis in 2023, is turning its biosimilar segment into a growth machine.

But there are many generic cleaning products that perform equally or even better. I have to agree with those who find that name-brand paper towels and window cleaner are usually worth the money.

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Over the past five years, the industry has traded as high as 11.64X, as low as 6.51X, and at the median of 9.21X, as the charts below show. 3 Generic Drug Stocks to Keep an Eye On Sandoz: This ...

"Sirens" was originally intended as a limited series, but does creator Molly Smith Metzler believe that there's more story to tell for Devon, Simone, Michaela and the rest?